These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 9122367

  • 21. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.
    Su YA, Si TM, Zhou DF, Guo CM, Wang XD, Yang Y, Shu L, Liang JH.
    Eur J Pharmacol; 2007 Jun 14; 564(1-3):123-30. PubMed ID: 17395179
    [Abstract] [Full Text] [Related]

  • 22. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
    Gleason SD, Shannon HE.
    Eur J Pharmacol; 1998 Jan 12; 341(2-3):135-8. PubMed ID: 9543230
    [Abstract] [Full Text] [Related]

  • 23. Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine.
    Bymaster FP, Falcone JF, Bauzon D, Kennedy JS, Schenck K, DeLapp NW, Cohen ML.
    Eur J Pharmacol; 2001 Nov 02; 430(2-3):341-9. PubMed ID: 11711053
    [Abstract] [Full Text] [Related]

  • 24. Neuropharmacology of light-induced locomotor activation.
    Amato D, Pum ME, Groos D, Lauber AC, Huston JP, Carey RJ, de Souza Silva MA, Müller CP.
    Neuropharmacology; 2015 Aug 02; 95():243-51. PubMed ID: 25842246
    [Abstract] [Full Text] [Related]

  • 25. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.
    Morisset S, Sahm UG, Traiffort E, Tardivel-Lacombe J, Arrang JM, Schwartz JC.
    J Pharmacol Exp Ther; 1999 Feb 02; 288(2):590-6. PubMed ID: 9918563
    [Abstract] [Full Text] [Related]

  • 26. Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism.
    Kargieman L, Riga MS, Artigas F, Celada P.
    Neuropsychopharmacology; 2012 Feb 02; 37(3):723-33. PubMed ID: 22012474
    [Abstract] [Full Text] [Related]

  • 27. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
    Rollema H, Lu Y, Schmidt AW, Sprouse JS, Zorn SH.
    Biol Psychiatry; 2000 Aug 01; 48(3):229-37. PubMed ID: 10924666
    [Abstract] [Full Text] [Related]

  • 28. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
    Oyamada Y, Horiguchi M, Rajagopal L, Miyauchi M, Meltzer HY.
    Behav Brain Res; 2015 May 15; 285():165-75. PubMed ID: 25448429
    [Abstract] [Full Text] [Related]

  • 29. The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats.
    Swanson CJ, Schoepp DD.
    J Pharmacol Exp Ther; 2002 Dec 15; 303(3):919-27. PubMed ID: 12438510
    [Abstract] [Full Text] [Related]

  • 30. Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss.
    Moy SS, Fernandes A, Qian Y, Rotella DJ, Kostrewa RM, Breese GR.
    Pharmacol Biochem Behav; 2004 May 15; 78(1):47-56. PubMed ID: 15159133
    [Abstract] [Full Text] [Related]

  • 31. Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.
    Bruins Slot LA, Kleven MS, Newman-Tancredi A.
    Neuropharmacology; 2005 Dec 15; 49(7):996-1006. PubMed ID: 16009387
    [Abstract] [Full Text] [Related]

  • 32. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex.
    Abekawa T, Ito K, Koyama T.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec 15; 374(3):177-93. PubMed ID: 17103144
    [Abstract] [Full Text] [Related]

  • 33. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit.
    Terranova JP, Chabot C, Barnouin MC, Perrault G, Depoortere R, Griebel G, Scatton B.
    Psychopharmacology (Berl); 2005 Aug 15; 181(1):134-44. PubMed ID: 15830220
    [Abstract] [Full Text] [Related]

  • 34. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.
    O'Neill MF, Hicks CA, Shaw G, Parameswaran T, Cardwell GP, O'Neill MJ.
    J Pharmacol Exp Ther; 1998 Dec 15; 287(3):839-46. PubMed ID: 9864262
    [Abstract] [Full Text] [Related]

  • 35. Phencyclidine supersensitivity in rats with neonatal dopamine loss.
    Moy SS, Breese GR.
    Psychopharmacology (Berl); 2002 May 15; 161(3):255-62. PubMed ID: 12021828
    [Abstract] [Full Text] [Related]

  • 36. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
    Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ.
    Neuropsychopharmacology; 1996 Aug 15; 15(2):116-24. PubMed ID: 8840347
    [Abstract] [Full Text] [Related]

  • 37. Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor.
    Cheetham SC, Heal DJ.
    Br J Pharmacol; 1993 Dec 15; 110(4):1621-9. PubMed ID: 8306109
    [Abstract] [Full Text] [Related]

  • 38. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine.
    Bakshi VP, Geyer MA.
    Psychopharmacology (Berl); 1995 Nov 15; 122(2):198-201. PubMed ID: 8848537
    [Abstract] [Full Text] [Related]

  • 39. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
    Li M, Sun T, Zhang C, Hu G.
    Psychopharmacology (Berl); 2010 Sep 15; 212(1):45-57. PubMed ID: 20623111
    [Abstract] [Full Text] [Related]

  • 40. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 15; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.